Schistosoma mansoni antigens alter the cytokine response in vitro during cutaneous leishmaniasis

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 7, 2011, Pages 856-863

  Bafica, Aline Michelle Barbosa ^a   Cardoso, Luciana Santos ^a,b   Oliveira, Sérgio Costa ^c   Loukas, Alex ^d   Varela, Giuseppe Tittoni ^a   Oliveira, Ricardo Riccio ^a   Bacellar, Olívia ^a,e   Carvalho, Edgar Marcelino ^a,e,f   Araújo, Maria Ilma ^a,e,f  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSIDADE DO ESTADO DA BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Inst Nacional de Ciência e Tecnologia em Doenças Tropicais   (Brazil)

^f ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Cutaneous leishmaniasis; PIII; S. Mansoni antigens; Sm29; SmTSP 2

Indexed keywords

SCHISTOSOMA MANSONI;

EID: 82255174141     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000700012     Document Type: Article

References (36)

1. Araujo MI, Hoppe B, Medeiros M Jr, Alcantara L, Almeida MC, Schriefer A, Oliveira RR, Kruschewsky R, Figueiredo JP, Cruz AA, Carvalho EM 2004. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis 190: 1797-1803.
2. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Sole D, Carvalho EM 2000. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 123: 145-148.
3. Atochina O, Harn D 2006. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 15: 461-468.
4. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70: 6734-6740.
5. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497-1506.
6. Berman JD 1997. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684-703.
7. Bogdan C, Gessner A, Solbach W, Rollinghoff M 1996. Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol 8: 517-525.
8. Cardoso LS, Araujo MI, Goes AM, Pacifico LG, Oliveira RR, Oliveira SC 2007. Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact 6: 1.
9. Cardoso LS, Oliveira SC, Goes AM, Oliveira RR, Pacifico LG, Marinho FV, Fonseca CT, Cardoso FC, Carvalho EM, Araujo MI 2010. Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol 160: 266-274.
10. Cardoso LS, Oliveira SC, Pacífico LG, Góes AM, Oliveira RR, Fonseca CT, Carvalho EM, Araújo MI 2006. Schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals. Mem Inst Oswaldo Cruz 101 (Suppl. I): 339-343.
11. Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, Dunne DW 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 21: 169-176.
12. Cooper PJ, Chico ME, Rodrigues LC, Ordonez M, Strachan D, Griffin GE, Nutman TB 2003. Reduced risk of atopy among schoolage children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 111: 995-1000.
13. Desjeux P 2001. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
14. Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, Dutra WO 2005. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73: 7853-7859.
15. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157-3166.
16. Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, Larner AC, Finbloom DS 1999. Interleukin-10 inhibits expression of both interferon alpha-and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93: 1456-1463.
17. Jaschke E, Zabernigg A, Gattringer C 1999. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol 38: 380-386.
18. Jones TC, Johnson WD Jr., Barretto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, Wiese K, Gollgthtly, Fikrig F, Costa JML, Cuba CC, Marsden PD 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156: 73-83.
19. Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, Carvalho EM 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65: 87-89.
20. Liew FY, Li Y, Millott S 1990. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145: 4306-4310.
21. Machado PR, Lessa H, Lessa M, Guimaraes LH, Bang H, Ho JL, Carvalho EM 2007. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 44: 788-793.
22. Medeiros M Jr., Almeida MC, Figueiredo JP, Atta AM, Mendes CM, Araujo MI, Taketomi EA, Terra SA, Silva DA, Carvalho EM 2004. Low frequency of positive skin tests in asthmatic patients infected with Schistosoma mansoni exposed to high levels of mite allergens. Pediatr Allergy Immunol 15: 142-147.
23. Medeiros M Jr., Figueiredo JP, Almeida MC, Matos MA, Araujo MI, Cruz AA, Atta AM, Rego MA, de Jesus AR, Taketomi EA, Carvalho EM 2003. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 111: 947-951.
24. Murray HW, Cartelli DM 1983. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and-independent leishmanicidal activity. J Clin Invest 72: 32-44.
25. Murray HW, Rubin BY, Rothermel CD 1983. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest 72: 1506-1510.
26. Newlove T, Guimaraes LH, Morgan DJ, Alcantara L, Glesby MJ, Carvalho EM, Machado PR 2011. Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis. Am J Trop Med Hyg 84: 551-555.
27. Oliveira RR, Gollob KJ, Figueiredo JP, Alcantara LM, Cardoso LS, Aquino CS, Campos RA, Almeida MC, Carvalho EM, Araujo MI 2009. Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect 11: 223-229.
28. O'Neal SE, Guimaraes LH, Machado PR, Alcantara L, Morgan DJ, Passos S, Glesby MJ, Carvalho EM 2007. Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J Infect Dis 195: 142-148.
29. + T cells independent of interleukin-10. Infect Immun 77: 98-107.
30. Ribeiro-de-Jesus A, Luna T, Pacheco de Almeida R, Machado PR, Carvalho EM 2008. Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections. Int Immunopharmacol 8: 1344-1353.
31. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM 1998. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31: 143-148.
32. Rocha PN, Almeida RP, Bacellar O, de Jesus AR, Filho DC, Filho AC, Barral A, Coffman RL, Carvalho EM 1999. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 180: 1731-1734.
33. Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15: 59-69.
34. Simpson AJ, Hagan P, Hackett F, Omer Ali P, Smithers SR 1990. Epitopes expressed on very low Mr Schistosoma mansoni adult tegumental antigens conform to a general pattern of life-cycle cross-reactivity. Parasitology 100: 73-81.
35. van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT, Tielens AG, Yazdanbakhsh M 2002. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 277: 48122-48129.
36. van der Kleij D, van den Biggelaar AH, Kruize YC, Retra K, Fillie Y, Schmitz M, Kremsner PG, Tielens AG, Yazdanbakhsh M 2004. Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis 189: 1044-1051.